Detalhe da pesquisa
1.
KRAS Allelic Imbalance Enhances Fitness and Modulates MAP Kinase Dependence in Cancer.
Cell
; 168(5): 817-829.e15, 2017 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28215705
2.
Cellular Therapy for Children with Central Nervous System Tumors: Mining and Mapping the Correlative Data.
Curr Oncol Rep
; 25(8): 847-855, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37160547
3.
Clinical and molecular heterogeneity of pineal parenchymal tumors: a consensus study.
Acta Neuropathol
; 141(5): 771-785, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33619588
4.
Phase 1 study of pomalidomide in children with recurrent, refractory, and progressive central nervous system tumors: A Pediatric Brain Tumor Consortium trial.
Pediatr Blood Cancer
; 68(2): e28756, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33025730
5.
A phase I trial of the CDK 4/6 inhibitor palbociclib in pediatric patients with progressive brain tumors: A Pediatric Brain Tumor Consortium study (PBTC-042).
Pediatr Blood Cancer
; 68(4): e28879, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33405376
6.
Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study.
Acta Neuropathol
; 139(2): 223-241, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31820118
7.
Limitations of Deep Learning Attention Mechanisms in Clinical Research: Empirical Case Study Based on the Korean Diabetic Disease Setting.
J Med Internet Res
; 22(12): e18418, 2020 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33325832
8.
Medulloblastoma rendered susceptible to NK-cell attack by TGFß neutralization.
J Transl Med
; 17(1): 321, 2019 09 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31547819
9.
Heterogeneity within the PF-EPN-B ependymoma subgroup.
Acta Neuropathol
; 136(2): 227-237, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30019219
10.
A pediatric brain tumor consortium phase II trial of capecitabine rapidly disintegrating tablets with concomitant radiation therapy in children with newly diagnosed diffuse intrinsic pontine gliomas.
Pediatr Blood Cancer
; 65(2)2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29090526
11.
Fluorescent Nanobiosensors for Sensing Glucose.
Sensors (Basel)
; 18(5)2018 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29734744
12.
The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants.
Acta Neuropathol
; 133(1): 5-12, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27858204
13.
Preclinical efficacy of MEK inhibition in Nras-mutant AML.
Blood
; 124(26): 3947-55, 2014 Dec 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-25361812
14.
Anaplastic Ependymoma in a Child With Sickle Cell Anemia: A Case Report Highlighting Treatment Challenges for Young Children With Central Nervous System Tumors and Underlying Vasculopathy.
Pediatr Blood Cancer
; 63(3): 547-50, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26488903
15.
Pediatric Brain Tumors: Current Knowledge and Therapeutic Opportunities.
J Pediatr Hematol Oncol
; 38(4): 249-60, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26989915
16.
An open-label, two-stage, phase II study of bevacizumab and lapatinib in children with recurrent or refractory ependymoma: a collaborative ependymoma research network study (CERN).
J Neurooncol
; 123(1): 85-91, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25859842
17.
Pediatric diffuse leptomeningeal glioneuronal tumor: Two clinical cases of successful targeted therapy.
Pediatr Blood Cancer
; 67(12): e28478, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32841504
18.
Inhibiting the palmitoylation/depalmitoylation cycle selectively reduces the growth of hematopoietic cells expressing oncogenic Nras.
Blood
; 119(4): 1032-5, 2012 Jan 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-22144181
19.
WHIM syndrome caused by a single amino acid substitution in the carboxy-tail of chemokine receptor CXCR4.
Blood
; 120(1): 181-9, 2012 Jul 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-22596258
20.
CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity.
Acta Neuropathol
; 128(2): 291-303, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24839957